| 000 | 01815 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516020403.0 | ||
| 264 | 0 | _c20110527 | |
| 008 | 201105s 0 0 eng d | ||
| 022 | _a1557-8852 | ||
| 024 | 7 |
_a10.1089/cbr.2010.0818 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFang, Shengwei | |
| 245 | 0 | 0 |
_aExperimental study on the therapeutic effect of positron emission tomography agent [¹⁸F]-labeled 2-deoxy-2-fluoro-d-glucose in a colon cancer mouse model. _h[electronic resource] |
| 260 |
_bCancer biotherapy & radiopharmaceuticals _cDec 2010 |
||
| 300 |
_a733-40 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAnimal Structures _xmetabolism |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aApoptosis _xradiation effects |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aColonic Neoplasms _xmetabolism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorodeoxyglucose F18 _xmetabolism |
| 650 | 0 | 4 |
_aGlucose Transporter Type 1 _xmetabolism |
| 650 | 0 | 4 |
_aGlucose Transporter Type 3 _xmetabolism |
| 650 | 0 | 4 |
_aGlucose Transporter Type 4 _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 | _aMice, Nude |
| 650 | 0 | 4 |
_aNecrosis _xpathology |
| 650 | 0 | 4 | _aPositron-Emission Tomography |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xmetabolism |
| 650 | 0 | 4 | _aXenograft Model Antitumor Assays |
| 700 | 1 | _aWang, Jing | |
| 700 | 1 | _aJiang, Han | |
| 700 | 1 | _aZhang, Ying | |
| 700 | 1 | _aXi, Wang | |
| 700 | 1 | _aZhao, Chunlei | |
| 700 | 1 | _aTian, Mei | |
| 700 | 1 | _aZhang, Hong | |
| 773 | 0 |
_tCancer biotherapy & radiopharmaceuticals _gvol. 25 _gno. 6 _gp. 733-40 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1089/cbr.2010.0818 _zAvailable from publisher's website |
| 999 |
_c20490497 _d20490497 |
||